Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Chan

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.
Epilepsia Open|August 7, 2025
Febrile status epilepticus and epileptogenesis: The FEBSTAT studyDarrell V Lewis, Douglas R Nordli, Douglas R Nordli, et al.
Plos One|July 9, 2015
Towards Automated Annotation of Benthic Survey Images: Variability of Human Experts and Operational Modes of AutomationOscar Beijbom, Peter J Edmunds, Chris Roelfsema, et al.
The Journal of Pediatrics|July 2, 2013
Risk factors for febrile status epilepticus: a case-control studyDale C Hesdorffer, Shlomo Shinnar, Darrell V Lewis, et al.
AJR. American Journal of Roentgenology|October 27, 2015
Hippocampal Malrotation Is Associated With Prolonged Febrile Seizures: Results of the FEBSTAT StudyStephen Chan, Jacqueline A Bello, Shlomo Shinnar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancerMartine J Piccart-Gebhart, Tomasz Burzykowski, Marc Buyse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancerTomasz Burzykowski, Marc Buyse, Martine J Piccart-Gebhart, et al.
Molecular Oncology|December 4, 2014
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M A Abdel-Fatah, Fiona K Middleton, Arvind Arora, et al.
Molecular Oncology|September 11, 2014
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Tarek M A Abdel-Fatah, Rachel Doherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancerStephen Chan, Gilles Romieu, Jens Huober, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.
Epilepsia Open|August 7, 2025
Febrile status epilepticus and epileptogenesis: The FEBSTAT studyDarrell V Lewis, Douglas R Nordli, Douglas R Nordli, et al.
Plos One|July 9, 2015
Towards Automated Annotation of Benthic Survey Images: Variability of Human Experts and Operational Modes of AutomationOscar Beijbom, Peter J Edmunds, Chris Roelfsema, et al.
The Journal of Pediatrics|July 2, 2013
Risk factors for febrile status epilepticus: a case-control studyDale C Hesdorffer, Shlomo Shinnar, Darrell V Lewis, et al.
AJR. American Journal of Roentgenology|October 27, 2015
Hippocampal Malrotation Is Associated With Prolonged Febrile Seizures: Results of the FEBSTAT StudyStephen Chan, Jacqueline A Bello, Shlomo Shinnar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancerMartine J Piccart-Gebhart, Tomasz Burzykowski, Marc Buyse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancerTomasz Burzykowski, Marc Buyse, Martine J Piccart-Gebhart, et al.
Molecular Oncology|December 4, 2014
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M A Abdel-Fatah, Fiona K Middleton, Arvind Arora, et al.
Molecular Oncology|September 11, 2014
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Tarek M A Abdel-Fatah, Rachel Doherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancerStephen Chan, Gilles Romieu, Jens Huober, et al.
Pageof 17